Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia

NCT03551496 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03551496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03551496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
Lead sponsor
Boston Scientific Corporation
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2018
Completion date
December 20, 2023
Enrollment
201 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia